Do pleiotropic effects of antihypertensive medications exist or is it all about the blood pressure?
Examination of the large-scale drug-versus-drug trials suggests that the initial drug choice is of token importance and that better blood pressure control is the primary determinant of superior outcomes. In pooled analyses, the achieved blood pressure is similar for older and less expensive drugs, such as thiazide-type diuretics, and for newer and more costly agents, such as angiotensin-converting enzyme inhibitors, -angiotensin-receptor blockers, and calcium-channel blockers. If blood pressure--independent differences favoring one antihypertensive drug class over another truly exist, they have been singularly difficult to uncover with any consistency. Considering that multidrug therapy is required in the majority of patients with hypertension, the debate as to which drug class is best to start with is moot, in that the clinician is now more called upon to decide the best combinations of drugs and not the best monotherapy.
Sica
Domenic A
DA
Division of Nephrology, Box 980160, MCV Station, Virginia Commonwealth University Health System, Richmond, Virginia 23298-0160, USA. dsica@mcvh-vcu.edu
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007249:Inflammation; D051436:Renal Insufficiency, Chronic / Q000209:etiology / Q000503:physiopathology; D012084:Renin-Angiotensin System / Q000187:drug effects
D000959:Antihypertensive Agents
Lancet. 1999 Feb 20;353(9153):611-6
10030325
Am J Manag Care. 2000 Feb;6(3 Suppl):S85-108; quiz S109-11
10977451
Hypertension. 2001 Dec 1;38(6):E28-32
11751742
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
JAMA. 2002 Dec 18;288(23):2981-97
12479763
Semin Nephrol. 2007 Mar;27(2):182-94
17418687
Lancet. 2002 Dec 14;360(9349):1903-13
12493255
Am J Cardiol. 2001 Aug 1;88(3):291-3
11472710
Ann Intern Med. 2003 Aug 19;139(4):244-52
12965979
Stroke. 2005 Jun;36(6):1218-26
15879332
N Engl J Med. 2003 Feb 13;348(7):583-92
12584366
Pharmacology. 2003 Dec;69(4):171-6
14624055
N Engl J Med. 2001 Sep 20;345(12):851-60
11565517
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003
17253471
Contrib Nephrol. 2001;(135):200-11
11705285
Circulation. 2006 Jun 13;113(23):2754-72; discussion 2773-4
16769926
Lancet. 2003 Sep 6;362(9386):782-8
13678872
Lancet. 2005 Oct 8;366(9493):1267-78
16214597
Lancet. 2004 Jun 19;363(9426):2022-31
15207952
N Engl J Med. 2001 Sep 20;345(12):861-9
11565518
Ann Intern Med. 2004 Jul 20;141(2):102-12
15262665
Curr Opin Nephrol Hypertens. 2007 Mar;16(2):59-63
17293678
Arch Intern Med. 2005 Jun 27;165(12):1410-9
15983291
Lancet. 2005 Dec 10;366(9502):2026-33
16338452
Hypertension. 2005 Aug;46(2):386-92
16009786
Lancet. 2000 Jul 29;356(9227):366-72
10972368
J Hypertens. 2007 May;25(5):951-8
17414657
Curr Med Res Opin. 2007 Feb;23(2):443-57
17288698
Circulation. 2002 Nov 5;106(19):2422-7
12417537
J Am Soc Nephrol. 2005 Jul;16(7):2170-9
15930097
N Engl J Med. 2000 Jan 20;342(3):145-53
10639539
N Engl J Med. 2004 Nov 11;351(20):2058-68
15531767
Lancet. 2000 Jul 29;356(9227):359-65
10972367
J Hypertens. 2003 Jun;21(6):1055-76
12777939
Lancet. 2001 Sep 29;358(9287):1033-41
11589932
Curr Opin Nephrol Hypertens. 2005 Sep;14(5):435-41
16046901
Lancet. 2003 Nov 8;362(9395):1527-35
14615107
Blood Press. 2003;12(3):160-7
12875478
Circulation. 2006 Jul 4;114(1):26-31
16801465
Blood Press Monit. 1999;4 Suppl 2:S17-21
10822418